Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging paradigms in GPCR allostery: implications for drug discovery
Denise Wootten, Arthur Christopoulos, Patrick M. Sexton
Nature Reviews Drug Discovery (2013) Vol. 12, Iss. 8, pp. 630-644
Closed Access | Times Cited: 445

Showing 1-25 of 445 citing articles:

Trends in GPCR drug discovery: new agents, targets and indications
Alexander S. Hauser, Misty M. Attwood, Mathias Rask‐Andersen, et al.
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 12, pp. 829-842
Open Access | Times Cited: 2266
The Current State of Peptide Drug Discovery: Back to the Future?
Antoine Henninot, James C. Collins, John M. Nuss
Journal of Medicinal Chemistry (2017) Vol. 61, Iss. 4, pp. 1382-1414
Closed Access | Times Cited: 939
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
Robert B. Laprairie, Amina M. Bagher, Michael E. Kelly, et al.
British Journal of Pharmacology (2015) Vol. 172, Iss. 20, pp. 4790-4805
Open Access | Times Cited: 859
GPCR Dynamics: Structures in Motion
Naomi R. Latorraca, AJ Venkatakrishnan, Ron O. Dror
Chemical Reviews (2016) Vol. 117, Iss. 1, pp. 139-155
Open Access | Times Cited: 674
Molecular control of δ-opioid receptor signalling
Gustavo Fenalti, Patrick M. Giguère, Vsevolod Katritch, et al.
Nature (2014) Vol. 506, Iss. 7487, pp. 191-196
Open Access | Times Cited: 475
Current Concepts and Treatments of Schizophrenia
Piotr Stępnicki, Magda Kondej, Agnieszka A. Kaczor
Molecules (2018) Vol. 23, Iss. 8, pp. 2087-2087
Open Access | Times Cited: 460
Muscarinic acetylcholine receptors: novel opportunities for drug development
Andrew C. Kruse, Brian K. Kobilka, Dinesh Gautam, et al.
Nature Reviews Drug Discovery (2014) Vol. 13, Iss. 7, pp. 549-560
Open Access | Times Cited: 389
Lipid Metabolism, Apoptosis and Cancer Therapy
Chunfa Huang, Carl E. Freter
International Journal of Molecular Sciences (2015) Vol. 16, Iss. 1, pp. 924-949
Open Access | Times Cited: 381
Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes
Chris de Graaf, Dan Donnelly, Denise Wootten, et al.
Pharmacological Reviews (2016) Vol. 68, Iss. 4, pp. 954-1013
Open Access | Times Cited: 315
Impact of GPCR Structures on Drug Discovery
Miles Congreve, Chris de Graaf, Nigel A. Swain, et al.
Cell (2020) Vol. 181, Iss. 1, pp. 81-91
Open Access | Times Cited: 299
Allosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation
Jean‐Pierre Changeux, Arthur Christopoulos
Cell (2016) Vol. 166, Iss. 5, pp. 1084-1102
Open Access | Times Cited: 285
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors
Mylyne Tham, Orhan Yılmaz, Mariam Alaverdashvili, et al.
British Journal of Pharmacology (2018) Vol. 176, Iss. 10, pp. 1455-1469
Open Access | Times Cited: 270
The Pharmacology and Function of Receptors for Short-Chain Fatty Acids
Daniele Bolognini, Andrew B. Tobin, Graeme Milligan, et al.
Molecular Pharmacology (2015) Vol. 89, Iss. 3, pp. 388-398
Open Access | Times Cited: 242
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders
P. Jeffrey Conn, Craig W. Lindsley, Jens Meiler, et al.
Nature Reviews Drug Discovery (2014) Vol. 13, Iss. 9, pp. 692-708
Open Access | Times Cited: 239
International Union of Basic and Clinical Pharmacology. XCVII. G Protein–Coupled Estrogen Receptor and Its Pharmacologic Modulators
Eric R. Prossnitz, Jeffrey B. Arterburn
Pharmacological Reviews (2015) Vol. 67, Iss. 3, pp. 505-540
Open Access | Times Cited: 232
Advances in therapeutic peptides targeting G protein-coupled receptors
Anthony P. Davenport, Conor C. G. Scully, Chris de Graaf, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 6, pp. 389-413
Open Access | Times Cited: 224
International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands
Arthur Christopoulos, Jean‐Pierre Changeux, William A. Catterall, et al.
Pharmacological Reviews (2014) Vol. 66, Iss. 4, pp. 918-947
Open Access | Times Cited: 223
Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders
Daniel J. Foster, P. Jeffrey Conn
Neuron (2017) Vol. 94, Iss. 3, pp. 431-446
Open Access | Times Cited: 218
Development of allosteric modulators of GPCRs for treatment of CNS disorders
Hilary Highfield Nickols, P. Jeffrey Conn
Neurobiology of Disease (2013) Vol. 61, pp. 55-71
Open Access | Times Cited: 216
Advances in G Protein-Coupled Receptor Allostery: From Function to Structure
Arthur Christopoulos
Molecular Pharmacology (2014) Vol. 86, Iss. 5, pp. 463-478
Open Access | Times Cited: 213
Novel Allosteric Modulators of G Protein-coupled Receptors
Patrick R. Gentry, Patrick M. Sexton, Arthur Christopoulos
Journal of Biological Chemistry (2015) Vol. 290, Iss. 32, pp. 19478-19488
Open Access | Times Cited: 188
Allosteric Modulator Discovery: From Serendipity to Structure-Based Design
Shaoyong Lu, Xinheng He, Duan Ni, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 14, pp. 6405-6421
Closed Access | Times Cited: 149
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 144
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update
Adriaan P. IJzerman, Kenneth A. Jacobson, Christa E. Müller, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 2, pp. 340-372
Open Access | Times Cited: 106
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Mingyang Zhang, Ting Chen, Xun Lu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 100
Page 1 - Next Page

Scroll to top